{"id":"dexfenfluramine","rwe":[{"pmid":"37584406","year":"2023","title":"2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.","finding":"","journal":"Journal of medicinal chemistry","studyType":"Clinical Study"},{"pmid":"35679331","year":"2022","title":"Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.","finding":"","journal":"British journal of clinical pharmacology","studyType":"Clinical Study"},{"pmid":"34611902","year":"2021","title":"Interventions for preventing weight gain after smoking cessation.","finding":"","journal":"The Cochrane database of systematic reviews","studyType":"Clinical Study"},{"pmid":"33895186","year":"2021","title":"Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know.","finding":"","journal":"Pharmacology & therapeutics","studyType":"Clinical Study"},{"pmid":"33765343","year":"2021","title":"Pharmacological and non-pharmacological strategies for obese women with subfertility.","finding":"","journal":"The Cochrane database of systematic reviews","studyType":"Clinical Study"}],"tags":[{"label":"dexfenfluramine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Alpha-1B adrenergic receptor","category":"target"},{"label":"ADRA1B","category":"gene"},{"label":"ADRA2C","category":"gene"},{"label":"SIGMAR1","category":"gene"},{"label":"A08AA04","category":"atc"},{"label":"Active","category":"status"},{"label":"Obesity","category":"indication"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Serotonin Agents","category":"pharmacology"},{"label":"Serotonin Receptor Agonists","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/isocarboxazid","drug":"isocarboxazid","action":"Monitor closely","effect":"May interact with Dexfenfluramine Hydrochloride, Isocarboxazid","source":"DrugCentral","drugSlug":"isocarboxazid"},{"url":"/drug/phenelzine","drug":"phenelzine","action":"Monitor closely","effect":"May interact with Dexfenfluramine Hydrochloride, Phenelzine","source":"DrugCentral","drugSlug":"phenelzine"},{"url":"/drug/selegiline","drug":"selegiline","action":"Monitor closely","effect":"May interact with Dexfenfluramine Hydrochloride, Selegiline","source":"DrugCentral","drugSlug":"selegiline"},{"url":"/drug/tranylcypromine","drug":"tranylcypromine","action":"Monitor closely","effect":"May interact with Dexfenfluramine Hydrochloride, Tranylcypromine","source":"DrugCentral","drugSlug":"tranylcypromine"}],"contraindications":["Alcoholism","Diabetes mellitus type 1","Diabetes mellitus type 2","Glaucoma","Hypertensive disorder","Pulmonary hypertension"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=DEXFENFLURAMINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:39:47.278674+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:39:52.777571+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DEXFENFLURAMINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:39:53.696438+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL248702/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:39:54.391964+00:00"}},"allNames":"dextrofenfluramine","offLabel":[],"synonyms":["dexfenfluramine","(+)-Fenfluramine","D-Fenfluramine","dextrofenfluramine","(S)-Fenfluramine","dexfenfluramine hydrochloride","dexfenfluramine HCl"],"timeline":[{"date":"1970-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1970-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Dextrofenfluramine","ecosystem":[{"indication":"Obesity","otherDrugs":[{"name":"amfetamine","slug":"amfetamine","company":"Ucb Inc"},{"name":"benzphetamine","slug":"benzphetamine","company":"Pharmacia And Upjohn"},{"name":"bupropion","slug":"bupropion","company":"Glaxosmithkline"},{"name":"chlorphentermine","slug":"chlorphentermine","company":"Parke Davis"}],"globalPrevalence":890000000}],"mechanism":{"target":"Alpha-1B adrenergic receptor","targets":[{"gene":"ADRA1B","source":"DrugCentral","target":"Alpha-1B adrenergic receptor","protein":"Alpha-1B adrenergic receptor"},{"gene":"ADRA2C","source":"DrugCentral","target":"Alpha-2C adrenergic receptor","protein":"Alpha-2C adrenergic receptor"},{"gene":"SIGMAR1","source":"DrugCentral","target":"Sigma non-opioid intracellular receptor 1","protein":"Sigma non-opioid intracellular receptor 1"},{"gene":"ADRA2B","source":"DrugCentral","target":"Alpha-2B adrenergic receptor","protein":"Alpha-2B adrenergic receptor"},{"gene":"ADRA1A","source":"DrugCentral","target":"Alpha-1A adrenergic receptor","protein":"Alpha-1A adrenergic receptor"},{"gene":"ADRA2A","source":"DrugCentral","target":"Alpha-2A adrenergic receptor","protein":"Alpha-2A adrenergic receptor"},{"gene":"SLC6A4","source":"DrugCentral","target":"Sodium-dependent serotonin transporter","protein":"Sodium-dependent serotonin transporter"},{"gene":"HTR1A","source":"DrugCentral","target":"5-hydroxytryptamine receptor 1A","protein":"5-hydroxytryptamine receptor 1A"},{"gene":"ADRB1","source":"DrugCentral","target":"Beta-1 adrenergic receptor","protein":"Beta-1 adrenergic receptor"},{"gene":"HTR1D","source":"DrugCentral","target":"5-hydroxytryptamine receptor 1D","protein":"5-hydroxytryptamine receptor 1D"}],"modality":"Small Molecule","drugClass":"dexfenfluramine","explanation":"","oneSentence":"","technicalDetail":"DEXFENFLURAMINE acts as a selective agonist of the 5-HT2C receptor, which is involved in regulating appetite and satiety. By activating this receptor, DEXFENFLURAMINE reduces food intake and promotes weight loss."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/832","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=DEXFENFLURAMINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DEXFENFLURAMINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:31:01.668669","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:39:56.046877+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"phentermine","drugSlug":"phentermine","fdaApproval":"1959-05-04","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fenfluramine","drugSlug":"fenfluramine","fdaApproval":"2020-06-25","patentExpiry":"Nov 3, 2033","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"diethylpropion","drugSlug":"diethylpropion","fdaApproval":"1959-08-06","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"mazindol","drugSlug":"mazindol","fdaApproval":"1973-06-14","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"sibutramine","drugSlug":"sibutramine","fdaApproval":"1997-11-22","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"lorcaserin","drugSlug":"lorcaserin","fdaApproval":"2012-06-27","relationship":"same-class"},{"drugName":"setmelanotide","drugSlug":"setmelanotide","fdaApproval":"2020-11-25","patentExpiry":"Oct 13, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"topiramate","drugSlug":"topiramate","fdaApproval":"1996-12-24","patentExpiry":"Nov 16, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"ephedrine","drugSlug":"ephedrine","fdaApproval":"","patentExpiry":"May 16, 2040","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"bupropion","drugSlug":"bupropion","fdaApproval":"1985-12-30","patentExpiry":"Jun 27, 2026","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"naltrexone","drugSlug":"naltrexone","fdaApproval":"1984-11-20","patentExpiry":"Oct 15, 2029","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"dexfenfluramine","indications":{"approved":[{"name":"Obesity","source":"DrugCentral","snomedId":414916001,"regulator":"FDA","usPrevalence":100000000,"globalPrevalence":890000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2024"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"phentermine","brandName":"phentermine","genericName":"phentermine","approvalYear":"1959","relationship":"same-class"},{"drugId":"fenfluramine","brandName":"fenfluramine","genericName":"fenfluramine","approvalYear":"2020","relationship":"same-class"},{"drugId":"diethylpropion","brandName":"diethylpropion","genericName":"diethylpropion","approvalYear":"1959","relationship":"same-class"},{"drugId":"mazindol","brandName":"mazindol","genericName":"mazindol","approvalYear":"1973","relationship":"same-class"},{"drugId":"sibutramine","brandName":"sibutramine","genericName":"sibutramine","approvalYear":"1997","relationship":"same-class"},{"drugId":"lorcaserin","brandName":"lorcaserin","genericName":"lorcaserin","approvalYear":"2012","relationship":"same-class"},{"drugId":"setmelanotide","brandName":"setmelanotide","genericName":"setmelanotide","approvalYear":"2020","relationship":"same-class"},{"drugId":"topiramate","brandName":"topiramate","genericName":"topiramate","approvalYear":"1996","relationship":"same-class"},{"drugId":"ephedrine","brandName":"ephedrine","genericName":"ephedrine","approvalYear":"","relationship":"same-class"},{"drugId":"bupropion","brandName":"bupropion","genericName":"bupropion","approvalYear":"1985","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04123613","phase":"PHASE2","title":"Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)","status":"COMPLETED","sponsor":"DiaMedica Therapeutics Inc","startDate":"2019-12-17","conditions":["Kidney Diseases"],"enrollment":79,"completionDate":"2022-03-16"},{"nctId":"NCT01296802","phase":"NA","title":"Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2006-04","conditions":["Amphetamine-Related Disorders","Amphetamine Abuse"],"enrollment":50,"completionDate":"2008-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000022034","MMSL":"4557","NDDF":"004127","UNII":"E35R3G56OV","VUID":"4024029","CHEBI":"CHEBI:439329","VANDF":"4020972","INN_ID":"5818","RXNORM":"155142","UMLSCUI":"C0011786","chemblId":"CHEMBL248702","ChEMBL_ID":"CHEMBL248702","KEGG_DRUG":"D03713","DRUGBANK_ID":"DB01191","PUBCHEM_CID":"66265","SNOMEDCT_US":"322047008","SECONDARY_CAS_RN":"3239-45-0","MESH_DESCRIPTOR_UI":"D020372"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"14.0 hours","clearance":"11.0 mL/min/kg","bioavailability":"89%","fractionUnbound":"0.66%","volumeOfDistribution":"11.0 L/kg"},"publicationCount":525,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"A08AA04","allCodes":["A08AA04"]},"biosimilarFilings":[],"recentPublications":[{"date":"2023 Aug 24","pmid":"37584406","title":"2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.","journal":"Journal of medicinal chemistry"},{"date":"2022 Dec","pmid":"35679331","title":"Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.","journal":"British journal of clinical pharmacology"},{"date":"2021 Oct 6","pmid":"34611902","title":"Interventions for preventing weight gain after smoking cessation.","journal":"The Cochrane database of systematic reviews"},{"date":"2021 Oct","pmid":"33895186","title":"Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know.","journal":"Pharmacology & therapeutics"},{"date":"2021 Mar 25","pmid":"33765343","title":"Pharmacological and non-pharmacological strategies for obese women with subfertility.","journal":"The Cochrane database of systematic reviews"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1970-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:39:56.046877+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}